Donepezil News
Hope Remains For Alzheimer's Sufferers
The National Institute of Clinical Excellence (NICE), who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (AriceptŪ), will hopefully re-appraise their decision...
U.S. Food And Drug Administration Approves ARICEPT(R) For Treatment Of Severe Alzheimer's Disease
Eisai and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for ARICEPT(R) (donepezil HCl tablets) for treatment of severe Alzheimer's disease (AD).
Brits unable to access Alzheimer's drugs
It appears that people in Britain suffering from Alzheimer's disease will be unlikely to benefit from the use of four drugs designed to treat the the degenerative brain disease.
Treatment Benefits Are Ongoing When Patients With Moderate to Severe Alzheimer's Disease Receive Memantine While Continuing Donepezil: Presented at ANA
Patients with moderate to severe Alzheimer's disease show benefits for up to 24 weeks when treated with memantine (Namenda) while continuing donepezil (Aricept) as background therapy, according to research presented here at the...
Thousands of Scots Alzheimer's sufferers will be denied drugs
Tens of thousands of Scots who suffer from Alzheimer's disease will be denied breakthrough drugs because they fail arbitrary tests, according to a leading dementia charity.